[Ip-health] Fwd: Is the DSM-5 a vehicle for high-profit patent extensions?

Suerie Moon suerie.moon at gmail.com
Fri Jan 24 23:14:16 PST 2014


Hi all, I thought this article might be of interest to ip-health readers,
Suerie Moon

Sent from my iPad

Begin forwarded message:

> Resent-From: <suerie_moon at hks.harvard.edu>
> From: "Edmond J. Safra Center for Ethics" <katy at ethics.harvard.edu>
> Date: January 24, 2014 10:57:09 PM GMT+01:00
> To: "Moon, Suerie" <Suerie_Moon at hks.harvard.edu>
> Subject: Is the DSM-5 a vehicle for high-profit patent extensions?
> Reply-To: "katy at ethics.harvard.edu" <katy at ethics.harvard.edu>
> 
> Having trouble viewing this email? Click here
> 							
> Is the DSM-5 a vehicle for high-profit patent extensions?
>  
> The Edmond J. Safra Center for Ethics is very proud to announce a new publication by Lab Fellow Lisa Cosgrove in Psychotherapy and Psychosomatics, on the institutional corruption of psychiatry and the pharmaceutical industry: "Tripartite Conflicts of Interest and High Stakes Patent Extensions in the DSM-5." The article has been chosen as Editors Choice no. 1 and will be made open access in next month's issue. 
>  
> This study provides new data on the interlocking conflicts of interest between DSM-5 panel members, principal investigators of clinical trials for drugs being tested for new mental disorder indications, and drug companies poised to manufacture the drugs for those indications.
>  
> We hope that you will read and share this important article, and tune in for our next podcast, in which Lisa Cosgrove and Gregg Fields will discuss this research further..
> 
> 
> For press inquiries, please contact Lisa Cosgrove at lisa.cosgrove at umb.edu
> Forward this email
>   	
> This email was sent to suerie_moon at hks.harvard.edu by katy at ethics.harvard.edu |  
> Update Profile/Email Address | Instant removal with SafeUnsubscribe™ | Privacy Policy.
> Edmond J. Safra Center for Ethics | Harvard University | 124 Mt. Auburn Street | Suite 520N | Cambridge | MA | 02138



More information about the Ip-health mailing list